These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24220913)

  • 1. Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL study.
    Villaseñor A; Flatt SW; Marinac C; Natarajan L; Pierce JP; Patterson RE
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):189-99. PubMed ID: 24220913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.
    Pierce BL; Ballard-Barbash R; Bernstein L; Baumgartner RN; Neuhouser ML; Wener MH; Baumgartner KB; Gilliland FD; Sorensen BE; McTiernan A; Ulrich CM
    J Clin Oncol; 2009 Jul; 27(21):3437-44. PubMed ID: 19470939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of association between physical functioning and breast cancer mortality: evidence from the Women's Healthy Eating and Living Study.
    Marinac C; Patterson RE; Villasenor A; Flatt SW; Pierce JP
    J Cancer Surviv; 2014 Sep; 8(3):402-9. PubMed ID: 24570214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors.
    George SM; Neuhouser ML; Mayne ST; Irwin ML; Albanes D; Gail MH; Alfano CM; Bernstein L; McTiernan A; Reedy J; Smith AW; Ulrich CM; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2220-8. PubMed ID: 20716617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soy food consumption and breast cancer prognosis.
    Caan BJ; Natarajan L; Parker B; Gold EB; Thomson C; Newman V; Rock CL; Pu M; Al-Delaimy W; Pierce JP
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):854-8. PubMed ID: 21357380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of the C-Reactive Protein Inflammatory Biomarker with Breast Cancer Incidence and Mortality in the Women's Health Initiative.
    Nelson SH; Brasky TM; Patterson RE; Laughlin GA; Kritz-Silverstein D; Edwards BJ; Lane D; Rohan TE; Ho GYF; Manson JE; LaCroix AZ
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1100-1106. PubMed ID: 28292922
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.
    Allin KH; Nordestgaard BG; Flyger H; Bojesen SE
    Breast Cancer Res; 2011 Jun; 13(3):R55. PubMed ID: 21639875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
    Andersen HH; Bojesen SE; Johansen JS; Ejlertsen B; Berg T; Tuxen M; Madsen K; Danø H; Flyger H; Jensen MB; Nielsen DL
    Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):662-670. PubMed ID: 38358318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups.
    Holm JB; Baggesen E; Cronin-Fenton D; Frystyk J; Bruun JM; Christiansen P; Borgquist S
    Sci Rep; 2024 Jun; 14(1):14486. PubMed ID: 38914635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.
    Pierce BL; Neuhouser ML; Wener MH; Bernstein L; Baumgartner RN; Ballard-Barbash R; Gilliland FD; Baumgartner KB; Sorensen B; McTiernan A; Ulrich CM
    Breast Cancer Res Treat; 2009 Mar; 114(1):155-67. PubMed ID: 18401703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-surgical highly sensitive C-reactive protein and prognosis in early-stage breast cancer.
    Tibau A; Ennis M; Goodwin PJ
    Breast Cancer Res Treat; 2013 Oct; 141(3):485-93. PubMed ID: 24072269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
    Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
    Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project.
    Kwan ML; Chen WY; Flatt SW; Weltzien EK; Nechuta SJ; Poole EM; Holmes MD; Patterson RE; Shu XO; Pierce JP; Caan BJ
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):32-41. PubMed ID: 23150063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary fiber is associated with circulating concentrations of C-reactive protein in breast cancer survivors: the HEAL study.
    Villaseñor A; Ambs A; Ballard-Barbash R; Baumgartner KB; McTiernan A; Ulrich CM; Neuhouser ML
    Breast Cancer Res Treat; 2011 Sep; 129(2):485-94. PubMed ID: 21455669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study.
    Bertram LA; Stefanick ML; Saquib N; Natarajan L; Patterson RE; Bardwell W; Flatt SW; Newman VA; Rock CL; Thomson CA; Pierce JP
    Cancer Causes Control; 2011 Mar; 22(3):427-35. PubMed ID: 21184262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis following the use of complementary and alternative medicine in women diagnosed with breast cancer.
    Saquib J; Parker BA; Natarajan L; Madlensky L; Saquib N; Patterson RE; Newman VA; Pierce JP
    Complement Ther Med; 2012 Oct; 20(5):283-90. PubMed ID: 22863642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients.
    Wulaningsih W; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Van Hemelrijck M
    Carcinogenesis; 2015 Oct; 36(10):1121-8. PubMed ID: 26130675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postdiagnosis weight change is associated with poorer survival in breast cancer survivors: A prospective population-based patient cohort study.
    Jung AY; Hüsing A; Behrens S; Krzykalla J; Obi N; Becher H; Chang-Claude J
    Int J Cancer; 2021 Jan; 148(1):18-27. PubMed ID: 32621760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study.
    Irwin ML; Smith AW; McTiernan A; Ballard-Barbash R; Cronin K; Gilliland FD; Baumgartner RN; Baumgartner KB; Bernstein L
    J Clin Oncol; 2008 Aug; 26(24):3958-64. PubMed ID: 18711185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study.
    Braithwaite D; Moore DH; Satariano WA; Kwan ML; Hiatt RA; Kroenke C; Caan BJ
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1115-25. PubMed ID: 22573797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.